Curative Effects of Cryosurgery Combined with Argon Plasma Coagulation Therapy for Advanced Central Lung Cancer by Artificial Trachea

Fuqiang Wen

2013-01-01

Abstract:Objective To assess the feasibility ,safety and clinical practicality value of cryosurgery combined with argon plasma coagulation(APC) therapy via bronchofibroscope for advanced central lung cancer by artificial trachea.Methods The clinical data of 41 cases of cryosurgery combined with argon plasma coagulation therapy via bronchofibroscope for advanced central lung cancer by artificial trachea from February 2011 to December 2012 were retrospectively analyzed. The curative effects were assessed before and after treatment. There were following evaluation indicators including preoperative, postoperative cough, hemoptysis, fever, dyspnea index, imaging examination, review of airway stenosis bronchoscopy etc. Results The research showed patients with cough relieving were 13 cases (31.7%), hemoptysis remission in 14 cases (34.1%), fever ease in 9 cases (22.0% ), preoperative dyspnea index 3.5±0.42, postoperative 1.8±0.33, imaging suggestive of obstructive pneumonia and atelectasis disappeared in 12 cases(29.3%), 27 cases (65.9%) improved, 39 cases effective, 2 cases no changes; bronchoscope checks completely effect in 17 cases(41.5%), partially effect in 21 cases (51.2%), invalid in 3 cases (7.3%). Conclusions cryosurgery combined with argon plasma coagulation therapy via bronchofibroscope for advanced central lung cancer by artificial trachea is feasible, safe and practical. It has the advantages of relieving cough, hemoptysis, fever, dyspnea, fewer complications etc, fewer complications and high security,which should be developed extensively in clinic.